Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Yield10 Bioscience Inc YTEN

Healthcare Biotechnology
Yield10 Bioscience, Inc. is an agricultural bioscience company that is leveraging advanced genetics to develop the oilseed Camelina sativa (Camelina) as a platform crop for large-scale production of sustainable seed products. These seed products include feedstock oils for renewable diesel and sustainable aviation biofuels; omega-3 (EPA and DHA+EPA) oils for pharmaceutical, nutraceutical and... see more

Recent & Breaking News (OTCQB:YTEN)

Yield10 Bioscience Announces Adjournment of Special Meeting of Stockholders to Solicit Sufficient Votes in Favor of the Key Proposals

Accesswire November 8, 2024

Yield10 Bioscience Announces Second Quarter 2024 Financial Results

GlobeNewswire August 14, 2024

Yield10 Bioscience Grants Nufarm a Commercial License to Omega-3 Assets for Producing Oil in Camelina, and Yield10 and Nufarm sign a Memorandum of Understanding for Sale of Assets

GlobeNewswire July 17, 2024

Rothamsted Research Grants Yield10 Bioscience an Exclusive, Global Commercial License to Advanced Technology for Producing Omega-3 Products in Camelina

GlobeNewswire June 17, 2024

Yield10 Bioscience Announces Addition of Camelina to INTERLINE® Herbicide Label

GlobeNewswire May 23, 2024

Yield10 Bioscience Announces First Quarter 2024 Financial Results

GlobeNewswire May 15, 2024

Yield10 Bioscience Announces Delisting from Nasdaq

GlobeNewswire May 15, 2024

Yield10 Bioscience Announces 1-for-24 Reverse Stock Split

GlobeNewswire May 1, 2024

Yield10 Bioscience Announces Fourth Quarter and Full Year 2023 Financial Results

GlobeNewswire April 1, 2024

Yield10 Bioscience to Announce Fourth Quarter and Full Year 2023 Financial Results and Host a Conference Call on Monday, April 1, 2024

GlobeNewswire March 28, 2024

Yield10 Bioscience Announces that the Plant Biosafety Office of the Canadian Food Inspection Agency has Cleared Genome-edited E3902 Camelina for Planting in Canada

GlobeNewswire March 26, 2024

USDA-APHIS Determines that Yield10 Bioscience's Omega-3 Camelina Varieties May Be Planted and Bred in the United States

GlobeNewswire March 21, 2024

Yield10 Bioscience Reports that Proprietary Varieties of Winter Camelina Show Tolerance to Commonly Used Herbicides in First Field Tests

GlobeNewswire February 29, 2024

Yield10 Bioscience Grants Global License to VISION Bioenergy Oilseeds for Herbicide Tolerant Camelina Cultivated for the Production of Biofuel Feedstock

GlobeNewswire February 14, 2024

Yield10 Bioscience Provides an Update on its Omega-3 Camelina Program

GlobeNewswire February 7, 2024

Yield10 Bioscience Files Request for Regulatory Status Review with USDA-APHIS for Camelina Designed to Produce the EPA and DHA Components of Omega-3 Oil

GlobeNewswire January 8, 2024

USDA-APHIS Determines that Yield10 Bioscience's Stacked Herbicide Tolerant Camelina May Be Planted and Bred in the United States

GlobeNewswire November 15, 2023

USDA-APHIS Determines that Yield10 Bioscience's Glufosinate Tolerant Camelina May Be Planted and Bred in the United States

GlobeNewswire November 15, 2023

Yield10 Bioscience Announces Third Quarter 2023 Financial Results

GlobeNewswire November 14, 2023

Yield10 Bioscience to Announce Third Quarter 2023 Financial Results and Host a Conference Call on Tuesday, November 14, 2023

GlobeNewswire November 8, 2023